1 - 25 of 39 results for author:"Sadee W." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents. Duan W., Gao L., Zhao W., Leon M., Sadee W., Webb A., Resnick K., Wu X., Ramaswamy B., Cohn D.E. et al. Transl Res 161:156-164(2013) · Mapped (1) |
| Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk. Papp A.C., Pinsonneault J.K., Wang D., Newman L.C., Gong Y., Johnson J.A., Pepine C.J., Kumari M., Hingorani A.D., Talmud P.J. et al. PLoS ONE 7:e31930-e31930(2012) · Mapped (6) |
| Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity. Wang D., Para M.F., Koletar S.L., Sadee W. Pharmacogenet. Genomics 21:652-664(2011) · Mapped (7) |
| Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Pinsonneault J.K., Han D.D., Burdick K.E., Kataki M., Bertolino A., Malhotra A.K., Gu H.H., Sadee W. Neuropsychopharmacology 36:1644-1655(2011) · Mapped (3) |
| Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Moyer R.A., Wang D., Papp A.C., Smith R.M., Duque L., Mash D.C., Sadee W. Neuropsychopharmacology 36:753-762(2011) · Mapped (4) |
| Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. Ni W., Ji J., Dai Z., Papp A., Johnson A.J., Ahn S., Farley K.L., Lin T.S., Dalton J.T., Li X. et al. PLoS ONE 5:e13792-e13792(2010) · Mapped (151) |
| Nicotinic alpha5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. Smith R.M., Alachkar H., Papp A.C., Wang D., Mash D.C., Wang J.C., Bierut L.J., Sadee W. Eur. J. Hum. Genet. 19:76-83(2011) · Mapped (3) |
| Allele-specific tumor spectrum in pten knockin mice. Wang H., Karikomi M., Naidu S., Rajmohan R., Caserta E., Chen H.Z., Rawahneh M., Moffitt J., Stephens J.A., Fernandez S.A. et al. Proc. Natl. Acad. Sci. U.S.A. 107:5142-5147(2010) · Mapped (16) |
| Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. Bertolino A., Taurisano P., Pisciotta N.M., Blasi G., Fazio L., Romano R., Gelao B., Lo Bianco L., Lozupone M., Di Giorgio A. et al. PLoS ONE 5:e9348-e9348(2010) · Mapped (4) |
| CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Beitelshees A.L., Navare H., Wang D., Gong Y., Wessel J., Moss J.I., Langaee T.Y., Cooper-DeHoff R.M., Sadee W., Pepine C.J. et al. Circ Cardiovasc Genet 2:362-370(2009) · Mapped (12) |
| Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans. Blasi G., Lo Bianco L., Taurisano P., Gelao B., Romano R., Fazio L., Papazacharias A., Di Giorgio A., Caforio G., Rampino A. et al. J. Neurosci. 29:14812-14819(2009) · Mapped (4) |
| Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. Roe B.E., Tilley M.R., Gu H.H., Beversdorf D.Q., Sadee W., Haab T.C., Papp A.C. PLoS ONE 4:e6704-e6704(2009) · Mapped (125) |
| Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. Bertolino A., Fazio L., Di Giorgio A., Blasi G., Romano R., Taurisano P., Caforio G., Sinibaldi L., Ursini G., Popolizio T. et al. J. Neurosci. 29:1224-1234(2009) · Mapped (8) |
| Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues. Alachkar H., Kataki M., Scharre D.W., Papp A., Sadee W. Neurosci. Lett. 448:120-124(2008) · Mapped (5) |
| Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Bertolino A., Fazio L., Caforio G., Blasi G., Rampino A., Romano R., Di Giorgio A., Taurisano P., Papp A., Pinsonneault J. et al. Brain 132:417-425(2009) · Mapped (4) |
| Genotyping panel for assessing response to cancer chemotherapy. Dai Z., Papp A.C., Wang D., Hampel H., Sadee W. BMC Med Genomics 1:24-24(2008) · Mapped (33) |
| Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Wang D., Chen H., Momary K.M., Cavallari L.H., Johnson J.A., Sadee W. Blood 112:1013-1021(2008) · Mapped (2) |
| The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia. Besecker B., Bao S., Bohacova B., Papp A., Sadee W., Knoell D.L. Am. J. Physiol. Lung Cell Mol. Physiol. 294:L1127-36(2008) · Mapped (1) |
| Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., Lee M.L., Xiao T., Papp A., Wang D. et al. Proc. Natl. Acad. Sci. U.S.A. 104:20552-20557(2007) · Mapped (4) |
| KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Beitelshees A.L., Gong Y., Wang D., Schork N.J., Cooper-Dehoff R.M., Langaee T.Y., Shriver M.D., Sadee W., Knot H.J., Pepine C.J. et al. Pharmacogenet. Genomics 17:719-729(2007) · Mapped (1) |
| Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Lim J.E., Pinsonneault J., Sadee W., Saffen D. Mol. Psychiatry 12:491-501(2007) · Mapped (3) |
| Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors. Pinsonneault J.K., Papp A.C., Sadee W. Hum. Mol. Genet. 15:2636-2649(2006) · Mapped (8) |
| Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Lim J.E., Papp A., Pinsonneault J., Sadee W., Saffen D. Mol. Psychiatry 11:649-662(2006) · Mapped (3) |
| Genetic variants of the human dipeptide transporter PEPT1. Anderle P., Nielsen C.U., Pinsonneault J., Krog P.L., Brodin B., Sadee W. J. Pharmacol. Exp. Ther. 316:636-646(2006) · UniProtKB (1) |
| Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. Zhang Y., Wang D., Johnson A.D., Papp A.C., Sadee W. J. Biol. Chem. 280:32618-32624(2005) · Mapped (10) |